






The chemistry of quinolinediones, and in particular, 
3-aminoquinoline-2,4-diones have been of interest to our 
group for a long time.1 In the literature, two derivatives of 
3-aminoquinoline-2,4-diones are mentioned in connection 
with their biological activity. 3-Amino-3-(4-fluorophenyl)-
1H-quinoline-2,4-dione is effective against oxidative stress-
related diseases2 and inhibits cisplatin-induced hearing 
loss through suppression of reactive oxygen species.3,4 
A similar effect is exhibited by 3-amino-6-fluoro-3-
(4-fluorophenyl)-1H-quinoline-2,4-dione.4 Therefore, we 
tried to prepare some 3-aminoquinoline-2,4-dione deriva-
tives with the 3-amino group fixed in a fused ring structure. 
3-Aminoquinoline-2,4(1H,3H)-diones were prepared in our 
laboratory from 3-chloroquinoline-2,4-diones and ammonia 
or primary amines.1a We found, that these compounds 
undergo molecular rearrangements when reacting with 
isocyanic acid that is formed from urea in boiling acetic 
acid. Through this synthetic route, 2,6-dihydroimidazo[1,5-c]-
quinolone-2,4-diones and rearranged 3,3a-dihydro-5H-
imidazo[4,5-c]quinazoline-3,5-diones, 3-(3-acylureido)-2,3-
dihydro-1H-indol-2-ones, and 4-alkylidene-1'H-spiro-
[imidazolidine-5,3'-indole]-2,2'-diones were prepared.1b,c 
Later we found that the preferable source of isocyanic acid 
is sodium cyanate and that an acceptable source of 
isothiocyanic acid is potassium thiocyanate, both in acetic 
acid solution. Under these conditions, we prepared new 
heterocycles, e. g., spiro-linked imidazoline-2-thiones and 
thioxo derivatives of imidazo[1,5-c]quinazolin-5-ones and 
imidazo[4,5-c]quinolin-4-ones.1g 
In an effort to discover an influence of other substituents 
in the molecule of the amine, we chose ethanolamine as an 
easily accessible and inexpensive reagent. In our last 
paper,1h we described its reaction with 3-chloroquinoline-
2,4-diones 1. According to expectations, 3-(2-hydroxy-
ethylamino)quinoline-2,4-diones 2 were obtained and their 
reaction with isocyanic acid afforded mainly 5-hydroxy-1-
(2-hydroxyethyl)-1H-spiro[imidazolidine-4,3'-indole]-2,2'-
diones 3, but also 3-(2-hydroxyethyl)-3,3a-dihydro-2H-
imidazo[4,5-c]quinoline-2,4-(5H)-diones 4 (Scheme 1).  
In this paper, the analogous reaction of compounds 2 
with isothiocyanic acid is described. The starting com-
pounds 2a–f were reacted with isothiocyanic acid 
generated in situ from potassium thiocyanate in acetic acid. 
The composition of products from this reaction was 
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different from that with isocyanic acid and comprised three 
different N-hydroxyethyl substituted 2-thioxo-1H-imidazo-
[4,5-c]quinolin-4-ones 5a,c,d,f, 6a,b,d,e,f, and 7b,e, and, in 
one case, a product of molecular rearrangement 8c with 
spiro[imidazo[5,1-b]oxazole-7,3'-indolin]-2'-one structure 
(Scheme 1, Table 1). It is noteworthy that the respective 
non-cyclized thioureas derived of compounds 2 were never 
isolated. 
It can be expected, that compounds 3 and 5 can probably 
arise from hydroxyethyl derivative 2 by known Marckwald 
synthesis.5 However, no strong acid is present in the 
reaction mixture. Therefore, we offer another inter-
pretation, based on the formation of isocyanic or isothio-
cyanic acids during the reaction. With moderately strong 
isocyanic acid (pKa 3.7),
6 arising from the isomerization of 
weak cyanic acid (pKa 5.4),
7 compounds 2a,b,d–f react to 
form1h compounds 3a,b and 4d–f.  However, isothiocyanic 
acid is a very strong acid (pKa –1.3)
7,8 and arises from the 
isomerization of weak thiocyanic acid (pKa 5.4).
7 Its 
reaction with 3-aminoquinoline-2,4(1H,3H)-diones 2 afforded 
not only compounds 5a,c,d,f which are thio analogs of 
products 4, obtained by the reaction with isocyanic acid, 
but also new structures containing sulfur atom, such as 
dealkylated products 7b,e, due to the influence of strong 
isothiocyanic acid.  
The explanation of the origin of the obtained compounds 
was based on the NMR spectroscopy. Yellow or orange 
compounds 5a,c,d,f were produced in moderate yield from 
compounds 2a,c,d,f through the reaction with HNCS. The 
signals of NCH2 protons resonate more downfield than the 
signals of OCH2 protons. It was surprising, however, the 
location was proved by 2D NMR (mainly HSQC and 
HSQC–TOCSY). Protons are situated on the periphery of a 
molecule and their resonance can be relatively easily 
influenced by different neighbouring groups.  
When compound 5a was kept for one month in DMSO-d6 
the NMR spectrum indicated conversion into compound 
6a, the product of a nucleophilic attack on compound 5a by 
H2O, with a yield of about 65%. Typical 
13C chemical 
shifts in the spectra of this condensation product agree with 
those in oxa-analog of compound 6a, except that it has a 
different alkyl substituent at N-3 atom.1i On the other hand, 
compounds 6 can also be an antecedent of compounds 5.1g 
Indeed, yellow compounds 5a,f were prepared in high 
yields through the dehydration of colorless 6a,f upon 
treatment with P2O5 (Scheme 2). However, the same treat-
ment of compound 6e does not result in compound 5e, 
instead, colorless compound 9e was isolated with 39% 
yield (Scheme 2). It is likely that this new compound must 
originate from C-debenzylation and subsequent S-benzylation 




R1 R2 Product (yield, %) 
2a Me Bu 5a (24), 6a (16), 2a* (26), N-methylisatin (7) 
2b Me Bn 6b (8), 7b (8) 
2c Me Ph 5c (11), 8c (49) 
2d Ph Bu 5d (30), 6d (9), 2d* (33), N-phenylisatin (3) 
2e Ph Bn 6e (27), 7e (8) 
2f Ph Ph 5f (31), 6f (23), N-phenylisatin (6) 
Table 1. Products of the reactions 
of compounds 2a–f with HNCS 
* Recovered starting material. 
In the first-order positive-ion ESI-MS spectra of 
compounds 5a,c,d,f, we observed three singly charged 
signals, which we assigned to [M+H]+, [M+Na]+, and 
[M+K]+. In the first-order negative-ion ESI-MS spectra of 
compounds 6, singly charged signals assigned to [M–H]–, 
[M+Cl]–, and [2M–H]– were detected. Moreover, singly 
charged ion with m/z 150 in the mass spectra of compounds 
6a,b and m/z 212 in the mass spectra of compounds 6d,e,f 
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assigned these ions to 1-[2-(methylamino)phenyl]ethanolate 
and 1-[2-(phehylamino)phenyl]ethanolate, respectively. 
We propose that these ions are products of in-source 
fragmentation of deprotonated molecular ion [M–H]–.  
The only product of molecular rearrangement is 
compound 8c, having two aliphatic quaternary carbons, 
unlike its isomer 5c. In agreement with our preceding 
results, this compound must originate from the molecular 
rearrangement of compound 6c (Scheme 3). In three cases 
(Table 1), the corresponding isatins were isolated in 
addition to the main product, which is indicative of the 
extensive degradation of the starting compound 2 by 
isothiocyanic acid. Compounds 7b,e (Scheme 3) arise from 
the debenzylation of starting compounds 2b,e, bearing a 
benzyl group at position 3. Such reaction, resulting from 
the presence of strongly acidic isothiocyanic acid, has been 
observed before.1a 
In conclusion, we would like to emphasize that our 
results provide new information about the behavior of 
reactive quinoline-2,4-dione systems. 3-(2-Hydroxyethyl-
amino)quinolinediones, prepared from 3-chloroquinoline-
dione and ethanolamine, react with isothiocyanic acid to 
form four different heterocyclic structures: three related 
imidazo[4,5-c]quinolin-4-ones and spiro[imidazo[5,1-b]-
oxazole-7,3'-indolin]-2'-one, a new tetracyclic spiro system 
that has not been previously described. Unfortunately, the 
latter compound arises in only one case and our 
experiments on the preparation of other similar spiro 
compounds were so far unsuccessful. This study also 
demonstrated a new example of benzyl group migration 
from carbon to sulfur atom. An important result is also 
dehydration of 9b-hydroxy-2-thioxo-4H-imidazo[4,5-c]-
quinolin-4-ones to 2-thioxo-4H-imidazo[4,5-c]quinolin-
4-ones enabling preparation of these compounds as the 
only product by the two-step reaction from starting 
3-aminoquinoline-2,4-diones. The prepared compounds are 
suitable for biological testing as well as further synthetic 
elaboration. 
Experimental 
IR spectra were recorded on a Smart OMNI-
Transmission Nicolet iS10 spectrophotometer in KBr 
pellets. 1H, 13C, and 15N NMR spectra were recorded on a 
Bruker Avance III HD 500 spectrometer (500, 125, and 
50 MHz, respectively) in DMSO-d6; the 
1H and 13C 
chemical shifts are given with respect to internal standard 
TMS; for 15N spectra, MeNO2 was used as an external 
standard in a co-axial capillary; signal assignments were 
carried out using APT and 2D experiments (gradient-selected 
(gs) 1H–1H COSY, gs-1H–1H TOCSY, gs-1H–13C HMQC,  
gs-1H–13C HMQC-RELAY, gs-1H–13C HMBC, gs-1H–15N 
HMBC).9–11 Mass spectra were recorded on a Bruker 
Daltonics amaZon X ion-trap mass spectrometer, equipped 
with an ESI source; individual samples were injected into 
the ESI source as MeOH–H2O solutions (concentration 
500 ng/ml) via a syringe pump with a constant flow rate of 
3 ml/min; m/z range 50–1500, electrospray voltage  
±4.2 kV, drying gas temperature 220°C, drying gas flow 
rate 6.0 dm3/min, nebulizer pressure 55.16 kPa, capillary 
exit voltage 140 V; N2 was used as both nebulizing and 
drying gas. Elemental analysis was carried out on a Thermo 
Fisher Scientific Flash EA 1112 elemental analyzer. Melting 
points were determined using a Kofler block. TLC was 
performed using Macherey-Nagel Alugram® SIL G/UV254 
foil plates; elution with PhH–AcOEt, 4:1, CHCl3–EtOH, 
9:1, or CHCl3–AcOEt, 7:3. Column chromatography was 
carried out on Merck silica gel (grade 60, 70–230 mesh); 
elution with CHCl3, then CHCl3–EtOH, 99:1→8:2, or PhH, 
then PhH–AcOEt, 99:1→8:2.  
Compounds 2a–f were prepared from the respective 
compounds 1a–f and ethanolamine.1a 
Reaction of compounds 2a–f with HNCS (General 
method). KSCN (0.874 g, 9 mmol) was added to a solution 
of compound 2a–f (1.5 mmol) in AcOH (4.5 ml), and the 
mixture was stirred for 3 h at 50°C. The course of the 
reaction was monitored by TLC. After cooling, the mixture 
was poured onto crushed ice (20 ml) and extracted with 
CHCl3 (5 × 15 ml) and then with AcOEt (5 × 15 ml). The 
combined extracts were dried with anhydrous Na2SO4 and 
evaporated to dryness. The residue was separated by 
column chromatography.  
3a-Butyl-3-(2-hydroxyethyl)-5-methyl-2-thioxo-2,3,3a,5-
tetrahydro-4H-imidazo[4,5-c]quinolin-4-one (5a) was 
prepared from compound 2a. Yield 24%. Orange solid. Mp 
135–137°C (PhH–cyclohexane). IR spectrum, ν, cm–1: 
3376, 2961, 2932, 2875, 1690, 1661, 1609, 1589, 1471, 
1439, 1389, 1334, 1287, 1255, 1230, 1211, 1178, 1160, 
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608, 520. 1H NMR spectrum, δ, ppm (J, Hz): 0.68 (3Н, t, 
J = 7.3, 4-CH3 Bu); 0.66–0.76 (2Н, m, 2-CH2 Bu); 1.02–
1.13 (2Н, m, 3-CH2 Bu); 1.81–1.90 (1H, m) and 2.33–2.41 
(1H, m, 1-CH2 Bu); 3.32 (3H, s, 5-CH3); 3.78–3.88 (3H, m, 
CH2O, NCH2); 4.03–4.10 (1H, m, NCH2); 4.90 (1H, br. s, 
OH); 7.32–7.37 (1Н, m, H-7); 7.43–7.47 (1Н, m, H-9); 
7.74–7.79 (1Н, m, H-8); 7.90–7.94 (1Н, m, H-6). 13C NMR 
spectrum, δ, ppm: 13.6 (C-4 Bu); 21.1 (C-3 Bu); 24.2 
(C-2 Bu); 29.9 (5-CH3); 36.5 (C-1 Bu); 47.2 (NCH2); 56.8 
(CH2O); 81.2 (C-3a); 116.0 (C-5a); 116.8 (C-9); 124.1 
(C-7); 125.8 (C-6); 135.7 (C-8); 141.7 (C-9a); 166.6 (C-4); 
183.8 (C-9b); 194.5 (C-2). Mass spectrum, m/z (Irel, %): 
685 [2M+Na]+ (5), 370 [M+K]+ (10), 354 [M+Na]+ (100), 
351 [2M+Ca]2+ (9), 332 [M+H]+ (12). Found, %: C 61.45; 
H 6.60; N 12.79; S 9.64. C17H21N3O2S. Calculated, %: 
C 61.61; H 6.39; N 12.68; S 9.67. 
3-(2-Hydroxyethyl)-5-methyl-3a-phenyl-2-thioxo-2,3,3a,5-
tetrahydro-4H-imidazo[4,5-c]quinolin-4-one (5c) was 
prepared from compound 2c. Yield 11%. Yellow solid. Mp 
170–177°C (PhH–hexane). IR spectrum, ν, cm–1: 3556, 
3056, 2937, 2897, 1678, 1608, 1588, 1491, 1468, 1447, 
1400, 1361, 1326, 1284, 1222, 1168, 1143, 1123, 1050, 
1001, 968, 952, 934, 809, 760, 724, 695, 664, 610, 571, 
529. 1H NMR spectrum, δ, ppm (J, Hz): 3.17–3.29 (1H, m) 
and 3.62–3.74 (1H, m, CH2O); 3.44 (3H, s, 5-CH3); 3.47–
3.59 (1H, m) and 3.68–3.80 (1H, m, NCH2); 4.73 (1H, t, 
J = 5.7, OH); 6.98–7.02 (2Н, m, H-2,6 Ph); 7.23–7.28 (1Н, 
m, H-7); 7.36–7.43 (4Н, m, H-9, H-3,4,5 Ph); 7.62–7.66 
(1Н, m, H-8); 7.82–7.92 (1Н, m, H-6). 13C NMR spectrum, 
δ, ppm: 30.4 (5-CH3); 47.4 (NCH2); 56.2 (CH2O); 83.4 
(C-3a); 116.7 (C-5a); 116.8 (C-9); 124.1 (C-7); 125.9 
(C-2,6 Ph); 126.1 (C-6); 130.1 (C-3,5 Ph); 130.4 (C-4 Ph); 
131.6 (C-1 Ph); 135.5 (C-8); 141.2 (C-9a); 165.0 (C-4); 
183.1 (C-9b); 195.0 (C-2). Mass spectrum, m/z (Irel, %): 725 
[2M+Na]+ (9), 390 [M+K]+ (7), 374 [M+Na]+ (100), 371 
[2M+Ca]2+ (8), 352 [M+H]+ (17). Found, %: C 64.86; 
H 4.91; N 11.77; S 9.00. C19H17N3O2S. Calculated, %: 
C 64.94; H 4.88; N 11.96; S 9.12. 
3a-Butyl-3-(2-hydroxyethyl)-5-phenyl-2-thioxo-2,3,3a,5-
tetrahydro-4H-imidazo[4,5-c]quinolin-4-one (5d) was 
prepared from compound 2d. Yield 30%. Yellow solid. Mp 
161–166°C (PhH–hexane). IR spectrum, ν, cm–1: 3454, 
3066, 2962, 2929, 2871, 1689, 1608, 1590, 1490, 1467, 
1432, 1385, 1340, 1322, 1281, 1245, 1225, 1164, 1108, 
1066, 1033, 1004, 962, 859, 777, 754, 733, 696, 633, 610, 
582, 516. 1H NMR spectrum, δ, ppm (J, Hz): 0.78 (3Н, t, 
J = 7.3, 4-CH3 Bu); 0.75–0.85 (2Н, m, 2-CH2 Bu); 1.07–
1.23 (2Н, m, 3-CH2 Bu); 2.15–2.27 (1H, m) and 2.48–2.55 
(1H, m, 1-CH2 Bu); 3.73–3.88 (3H, m, CH2O, NCH2); 4.05–
4.11 (1H, m, NCH2); 4.83 (1H, t, J = 5.3, OH); 6.39–6.44 
(1Н, m, H-9); 7.27–7.34 (3H, m, H-7, H-2,6 Ph); 7.47–7.64 
(4H, m, H-8, H-3,4,5 Ph); 7.96–8.01 (1Н, m, H-6). 
13C NMR spectrum, δ, ppm: 13.6 (C-4 Bu); 21.1 (C-3 Bu); 
24.4 (C-2 Bu); 36.4 (C-1 Bu); 47.2 (NCH2); 56.8 (CH2O); 
81.5 (C-3a); 115.7 (C-9); 117.3 (C-5a); 124.1 (C-7); 125.9 
(C-6); 129.4 (C-2,6 Ph); 129.9 (C-4 Ph); 130.3 (C-3,5 Ph); 
130.4 (C-1 Ph); 136.8 (C-8); 142.8 (C-9a); 166.9 (C-4); 
183.7 (C-9b); 194.9 (C-2). Mass spectrum, m/z (Irel, %): 
809 [2M+Na]+ (5), 432 [M+K]+ (11), 416 [M+Na]+ (100), 
413 [2M+Ca]2+ (11), 394 [M+H]+ (15). Found, %: C 67.05; 
H 6.10; N 10.65; S 8.02. C22H23N3O2S. Calculated, %: 
C 67.15; H 5.89; N 10.68; S 8.15. 
3-(2-Hydroxyethyl)-3a,5-diphenyl-2-thioxo-2,3,3a,5-
tetrahydro-4H-imidazo[4,5-c]quinolin-4-one (5f) was 
prepared from compound 2f. Yield 31%. Orange solid. Mp 
178–180°C (PhH–cyclohexane). IR spectrum, ν, cm–1: 
3451, 3061, 2361, 1702, 1608, 1587, 1492, 1466, 1449, 
1394, 1359, 1309, 1289, 1246, 1229, 1165, 1140, 1060, 
1037, 1003, 953, 771, 733, 721, 703, 694, 671, 611, 594, 
568, 516. 1H NMR spectrum, δ, ppm (J, Hz): 3.10–3.19 
(1H, m) and 3.59–3.66 (1H, m, CH2O); 3.49–3.58 (1H, m) 
and 3.79–3.86 (1H, m, NCH2); 4.68 (1H, t, J = 5.7, OH); 
6.29–6.34 (1Н, m, H-9); 7.17–7.26 (3H, m, H-7, H-2,6 
3a-Ph); 7.39–7.69 (9H, m, H-8, H 5-Ph, H-3,4,5 3a-Ph); 
7.97–8.02 (1Н, m, H-6). 13C NMR spectrum, δ, ppm: 47.3 
(NCH2); 56.1 (CH2O); 83.6 (C-3a); 116.6 (C-5a); 117.4 
(C-9); 124.4 (C-7); 126.1 (C-2,6 3a-Ph); 126.3 (C-6); 128.9 
(C-2,6 5-Ph); 130.1 (C-4 5-Ph); 130.3 (C-3,5 3a,5-Ph); 
130.5 (C-4 3a-Ph); 131.5 (C-1 5-Ph); 135.1 (C-8); 136.8 
(C-1 3a-Ph); 142.3 (C-9a); 165.2 (C-4); 182.9 (C-9b); 
195.0 (C-2). Mass spectrum, m/z (Irel, %): 849 [2M+Na]
+ 
(8), 452 [M+K]+ (8), 436 [M+Na]+ (100), 433 [2M+Ca]2+ 
(21), 414 [M+H]+ (16). Found, %: C 69.81; H 4.75; 
N 10.18; S 7.74. C24H19N3O2S. Calculated, %: C 69.71; 
H 4.63; N 10.16; S 7.75. 
3a-Butyl-9b-hydroxy-3-(2-hydroxyethyl)-5-methyl-2-
thioxo-1,2,3,3a,5,9b-hexahydro-4H-imidazo[4,5-c]quinolin-
4-one (6a) was prepared from compound 2a. Yield 16%. 
Colorless solid. Mp 203–217°C (AcOEt). IR spectrum, 
ν, cm–1: 3418, 3226, 2958, 2933, 2871, 1662, 1605, 1478, 
1436, 1365, 1303, 1255, 1205, 1170, 1122, 1054, 1005, 
989, 956, 939, 910, 865, 843, 757, 721, 691, 623, 590, 518, 
490. 1H NMR spectrum, δ, ppm (J, Hz): 0.68 (3Н, t, J = 7.3, 
4-CH3 Bu); 0.70–0.76 (1H, m) and 0.92–1.01 (1H, m, 2-
CH2 Bu); 1.07–1.15 (2Н, m, 3-CH2 Bu); 1.95 (2H, m, 1-CH2 
Bu); 3.29 (3H, s, 5-CH3); 3.57–3.65 (2H, m, CH2O); 3.83–
3.90 (2H, m, NCH2); 4.60 (1H, t, J = 6.4, OH); 6.87 (1H, s, 
9b-OH); 7.12–7.20 (2H, m, H-6,8); 7.38–7.43 (1H, m, 
H-7); 7.72–7.79 (1H, m, H-9); 9.14 (1H, s, NH). 13C NMR 
spectrum, δ, ppm: 13.5 (C-4 Bu); 22.5 (C-3 Bu); 24.1 
(C-2 Bu); 29.4 (5-CH3); 31.3 (C-1 Bu); 46.4 (NCH2); 59.0 
(CH2O); 72.3 (C-3a); 84.7 (C-9b); 114.5 (C-6); 123.3 
(C-8); 123.7 (C-9a); 126.3 (C-9); 130.0 (C-7); 136.2 (C-5a); 
168.6 (C-4); 181.3 (C-2). 15N NMR spectrum, δ, ppm (J, Hz): 
–237.9 (d, 1J = 95.6, 1-NH); –252.6 (N-5); –253.3 (N-3). 
Mass spectrum, m/z (Irel, %): 721.2 [2M+Na]
+ (5), 388 
[M+K]+ (11), 372 [M+Na]+ (100), 369 [2M+Ca]2+ (26), 
350 [M+H]+ (6). Mass spectrum, m/z (Irel, %): 697 [2M–H]
– 
(66), 384 [M+35Cl]– (23), 348 [M–H]– (100), 150 (86). 
Found, %: C 58.36; H 6.74; N 11.86; S 8.98. C17H23N3O3S. 
Calculated, %: C 58.43; H 6.63; N 12.02; S 9.18. 
3a-Benzyl-9b-hydroxy-3-(2-hydroxyethyl)-5-methyl-
2-thioxo-1,2,3,3a,5,9b-hexahydro-4H-imidazo[4,5-c]-
quinolin-4-one (6b) was prepared from compound 2b. 
Yield 8%. Colorless solid. Mp 205–215°C (PhH–cyclo-
hexane). IR spectrum, ν, cm–1: 3244, 2937, 2887, 1662, 
1606, 1477, 1410, 1369, 1304, 1249, 1197, 1132, 1075, 
1034, 1016, 961, 944, 896, 832, 790, 756, 740, 701, 621, 
596, 550, 526, 456. 1H NMR spectrum, δ, ppm (J, Hz): 
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3.35 (3Н, s, 5-CH3); 3.65–3.81 (2H, s, CH2O); 4.04–4.08 
(2H, m, NCH2); 4.65 (1H, t, J = 6.3, OH); 6.54–6.56 (1H, 
m, H-6); 6.81–6.93 (5H, m, H Ph); 6.97–7.02 (1H, m, H-8); 
7.07–7.12 (1H, m, H-7); 7.15 (1H, s, 9b-OH); 7.64–7.67 
(1H, m, H-9); 9.19 (1H, s, NH). 13C NMR spectrum, 
δ, ppm: 29.0 (5-CH3); 36.2 (CH2Ph); 46.9 (NCH2); 59.2 
(CH2O); 72.9 (C-3a); 84.7 (C-9b); 113.6 (C-6); 122.6 (C-8); 
123.0 (C-9a); 126.1 (C-9); 126.7 (C-4 Ph); 126.8 (C-3,5 Ph); 
129.2 (C-7); 130.0 (C-2,6 Ph); 132.2 (C-1 Ph); 135.6 
(C-5a); 168.1 (C-4); 181.8 (C-2). 15N NMR spectrum, 
δ, ppm (J, Hz): –237.9 (d, 1J = 95.6, 1-NH); –250.3 (N-5); 
–254.0 (N-3). Mass spectrum, m/z (Irel, %): 789 [2M+Na]
+ 
(10), 422 [M+K]+ (13), 406 [M+Na]+ (100), 403 [2M+Ca]2+ 
(15), 384 [M+H]+ (4). Mass spectrum, m/z (Irel, %): 765 
[2M–H]– (47), 418 [M+35Cl]– (9), 382 [M–H]– (100), 150 
(57). Found, %: C 62.83; H 5.51; N 10.84; S 8.53. 




4-one (6d) was prepared from compound 2d. Yield 9%. 
White solid. Mp 220–226°C (PhH). IR spectrum, ν, cm–1: 
3283, 3169, 2958, 2932, 2872, 1654, 1606, 1596, 1464, 
1430, 1398, 1356, 1304, 1257, 1207, 1127, 1070, 1051, 
1006, 966, 945, 857, 754, 720, 699, 681, 649, 628, 586, 
511. 1H NMR spectrum, δ, ppm (J, Hz): 0.78 (3Н, t, 
J = 7.0, 4-CH3 Bu); 1.12–1.31 (4H, m, 2,3-CH2 Bu); 1.99–
2.12 (2H, m, 1-CH2 Bu); 3.59–3.67 (2H, m, CH2O); 3.75–
3.81 (1H, m) and 3.86–3.93 (1H, m, NCH2); 4.60 (1H, t, 
J = 6.2, OH); 6.14–6.17 (1H, m, H-6); 7.00 (1H, s, 9b-OH); 
7.11–7.24 (4H, m, H-7,8, H-2,6 Ph); 7.50–7.54 (1H, m, 
H-4 Ph); 7.57–7.62 (2Н, m, H-3,5 Ph); 7.81–7.84 (1H, m, 
H-9); 9.28 (1H, s, NH). 13C NMR spectrum, δ, ppm: 13.5 
(C-4 Bu); 22.5 (C-3 Bu); 24.3 (C-2 Bu); 31.7 (C-1 Bu); 
46.6 (NCH2); 59.0 (CH2O); 72.5 (C-3a); 85.1 (C-9b); 115.5 
(C-6); 123.4 (C-8,9a); 126.8 (C-9); 128.3 (C-2,6 Ph); 128.7 
(C-4 Ph); 129.6 (C-7); 130.2 (C-3,5); 137.1 (C-5a); 137.4 
(C-1 Ph); 168.9 (C-4); 181.5 (C-2). 15N NMR spectrum, 
δ, ppm (J, Hz): –231.0 (N-5); –237.7 (d, 1J = 96.0, 1-NH); 
–254.6 (N-3). Mass spectrum, m/z (Irel, %): 845 [2M+Na]
+ 
(7), 450 [M+K]+ (20), 434 [M+Na]+ (100), 431 [2M+Ca]2+ 
(12), 412 [M+H]+ (3). Mass spectrum, m/z (Irel, %): 821 
[2M–H]– (21), 446 [M+35Cl]– (27), 410 [M–H]– (29), 212 
(100). Found, %: C 64.14; H 6.28; N 9.98; S 7.85. 




quinolin-4-one (6e) was prepared from compound 2e. 
Yield 27%. Colorless solid. Mp 243–247°C (AcOEt). 
IR spectrum, ν, cm–1: 3387, 3192, 2933, 1652, 1598, 1491, 
1475, 1432, 1397, 1358, 1303, 1239, 1199, 1134, 1067, 
1038, 970, 854, 811, 755, 744, 717, 701, 608, 545, 524. 
1H NMR spectrum, δ, ppm (J, Hz): 3.28 (1H, d, J = 16.0) 
and 3.54 (1H, d, J = 16.0, CH2Ph); 3.63–3.69 (1H, m) and 
3.71–3.77 (1H, m, CH2O); 3.97–4.06 (2H, m, NCH2); 4.67 
(1H, t, J = 6.3, OH); 5.59–5.64 (1H, m, H-6); 6.70–6.85 
(2H, m, H Ph); 6.90–7.15 (7H, m, H-7,8, H Ph); 7.38 (1H, 
s, 9b-OH); 7.38–7.53 (3H, m, H Ph); 7.75–7.80 (1H, m, 
H-9); 9.39 (1H, s, NH). 13C NMR spectrum, δ, ppm: 36.3 
(CH2Ph); 46.9 (NCH2); 59.2 (CH2O); 73.3 (C-3a); 85.1 (C-9b); 
115.1 (C-6); 123.0 (C-8); 123.1 (C-9a); 126.5 (C-9); 127.1 
(C-4 5-Ph); 127.3 (C-3,5 5-Ph); 128.6 (C-3,5 CH2Ph); 
129.1 (C-4 CH2Ph); 130.0 (C-7); 130.8 (C-2,6 CH2Ph); 
132.4 (C-1 CH2Ph); 136.8 (C-5a); 137.1 (C-1 5-Ph); 167.9 
(C-4); 181.8 (C-2). Mass spectrum, m/z (Irel, %): 913 
[2M+Na]+ (8), 484 [M+K]+ (27), 468 [M+Na]+ (100), 465 
[2M+Ca]2+ (7), 446 [M+H]+ (10). Mass spectrum, m/z (Irel, %): 
889 [2M–H]– (21), 480 [M+35Cl]– (43), 444 [M–H]– (22), 
212 (100). Found, %: C 67.36; H 5.28; N 9.24; S 7.27. 
C25H23N3O3S. Calculated, %: C 67.40; H 5.20; N 9.43; S 7.20. 
9b-Hydroxy-3-(2-hydroxyethyl)-3a,5-diphenyl-2-thioxo-
1,2,3,3a,5,9b-hexahydro-4H-imidazo[4,5-c]quinolin-4-one 
(6f) was prepared from compound 2f. Yield 23%. Colorless 
solid. Mp 228–235°C (AcOEt). IR spectrum, ν, cm–1: 3230, 
2957, 1685, 1661, 1605, 1594, 1491, 1464, 1431, 1390, 1341, 
1307, 1260, 1195, 1140, 1077, 996, 945, 930, 863, 832, 
759, 735, 704, 691, 630, 606, 589, 574, 532, 513. 1H NMR 
spectrum, δ, ppm (J, Hz): 3.27–3.40 (1H, m, NCH2); 3.60–
3.74 (2H, m, NCH2, OCH2); 3.87–3.99 (2H, m, OCH2); 
4.55 (1H, t, J = 5.7, OH); 6.29–6.33 (1H, m, H-6); 7.00 
(1H, s, 9b-OH); 7.07–7.13 (1H, m, H-8); 7.20–7.26 (1H, m, 
H-7); 7.27–7.50 (7H, m, H-2,6 5-Ph, H-2,3,4,5,6 3a-Ph); 
7.53–7.58 (1H, m, H-4 5-Ph); 7.61–7.69 (2Н, m, H-9, H-3,5 
5-Ph); 9.55 (1H, s, NH). 13C NMR spectrum, δ, ppm: 48.7 
(NCH2); 58.4 (CH2O); 79.0 (C-3a); 86.5 (C-9b); 116.2 (C-6); 
122.5 (C-9a); 123.5 (C-8); 128.0 (C-9); 128.2 (C-2,6 3a-Ph); 
128.8 (C-3,5 3a-Ph, C-2,6 5-Ph); 129.9 (C-7); 130.3 (C-3,5 
5-Ph); 131.8 (C-1 3a-Ph); 137.4 (C-5a); 137.6 (C-1 5-Ph); 
168.0 (C-4); 184.5 (C-2). Mass spectrum, m/z (Irel, %): 885 
[2M+Na]+ (4), 470 [M+K]+ (15), 454 [M+Na]+ (100), 451 
[2M+Ca]2+ (9), 432 [M+H]+ (5). Mass spectrum, m/z (Irel, %): 
861 [2M–H]– (4), 466 [M+35Cl]– (20), 430 [M–H]– (59), 
212 (100). Found, %: C 66.64; H 4.93; N 9.53; S 7.68. 
C24H21N3O3S. Calculated, %: C 66.80; H 4.91; N 9.74; S 7.43. 
3-(2-Hydroxyethyl)-5-methyl-2-thioxo-1,2,3,5-tetrahydro-
4H-imidazo[4,5-c]quinolin-4-one (7b) was prepared from 
compound 2b. Yield 8%. Yellowish solid. Mp 295–310°C 
(cyclohexane–AcOEt). IR spectrum, ν, cm–1: 3347, 3074, 
2925, 2842, 2730, 1670, 1635, 1587, 1524, 1483, 1427, 
1393, 1358, 1327, 1261, 1211, 1164, 1115, 1074, 1063, 
1043, 1009, 969, 884, 863, 768, 754, 733, 677, 626, 585, 
520. 1H NMR spectrum, δ, ppm (J, Hz): 3.66 (3H, s, CH3); 
3.71 (2H, t, J = 6.6, CH2O); 4.56 (2H, t, J = 6.6, NCH2); 
4.84 (1H, br. s, OH); 7.31–7.36 (1H, m, H-8); 7.52–7.62 
(1H, m, H-6,7); 8.05–8.09 (1H, m, H-9); 13.75 (1H, s, 
NH). 13C NMR spectrum, δ, ppm: 28.9 (CH3); 46.3 
(NCH2); 58.4 (CH2O); 110.0 (C-3a); 115.7 (C-6); 117.7 
(C-9a); 122.0 (C-8); 122.5 (C-9); 129.4 (C-7); 131.5 
(C-9b); 136.8 (C-5a); 153.2 (C-2); 167.1 (C-4). 15N NMR 
spectrum, δ, ppm (J, Hz): –220.3 (N-3); –223.1 (d, 1J = 97.5, 
1-NH); –240.0 (N-5). Mass spectrum, m/z (Irel, %): 573 
[2M+Na]+ (73), 432.5 [3M+Ca]2+ (11), 314 [M+K]+ (9), 
298 [M+Na]+ (100), 276 [M+H]+ (21). Mass spectrum,  
m/z (Irel, %): 571 [2M–2H+Na]
– (12), 274 [M–H]– (100). 
Found, %: C 56.48; H 4.66; N 15.01; S 11.84. 
C13H13N3O2S. Calculated, %: C 56.71; H 4.76; N 15.26; 
S 11.65. 
3-(2-Hydroxyethyl)-5-phenyl-2-thioxo-1,2,3,5-tetrahydro-
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compound 2e. Yield 8%. Colorless solid. Mp 275–290°C 
(AcOEt). IR spectrum, ν, cm–1: 3426, 3056, 2924, 2740, 
1668, 1634, 1591, 1569, 1521, 1480, 1463, 1434, 1394, 
1341, 1324, 1267, 1238, 1210, 1164, 1121, 1072, 1029, 
989, 860, 786, 753, 732, 699, 683, 608, 563, 515. 1H NMR 
spectrum, δ, ppm (J, Hz): 3.71 (2H, td, J = 6.7, J = 5.7, 
CH2O); 4.56 (2H, t, J = 6.7, NCH2); 4.88 (1H, t, J = 5.7, OH); 
6.56–6.61 (1H, m, H-6); 7.31–7.45 (4H, m, H-7,8, H-2,6 Ph); 
7.55–7.68 (3H, m, H-3,4,5 Ph); 8.16–8.20 (1H, m, H-9); 
13.95 (1H, s, NH). 13C NMR spectrum, δ, ppm: 46.4 (NCH2); 
58.5 (CH2O); 110.1 (C-3a); 116.5 (C-6); 117.9 (C-9a); 
122.1 (C-9); 122.8 (C-8); 129.0 (C-4 Ph); 129.3 (C-7); 129.4 
(C-2,6 Ph); 130.1 (C-3,5 Ph); 132.4 (C-9b); 137.2 (C-5a); 
138.3 (C-1 Ph); 152.5 (C-2); 167.4 (C-4). 15N NMR spectrum, 
δ, ppm (J, Hz): –219.1 (N-5); –220.3 (N-3); –223.9 (d, 
1J = 96.6, 1-NH). Mass spectrum, m/z (Irel, %): 697 
[2M+Na]+ (14), 376 [M+K]+ (11), 360 [M+Na]+ (100), 338 
[M+H]+ (16). Mass spectrum, m/z (Irel, %): 336 [M–H]
– (100). 
Found, %: C 63.95; H 4.50; N 11.98; S 9.27. C18H15N3O2S. 
Calculated, %: C 64.08; H 4.48; N 12.45; S 9.50. 
1'-Methyl-7a-phenyl-5-thioxo-2,3,5,6-tetrahydro-7aH-
spiro[imidazo[5,1-b]oxazole-7,3'-indolin]-2'-one (8c) was 
prepared from compound 2c. Yield 49%. White solid. Mp 
221–224°C (hexane–AcOEt). IR spectrum, ν, cm–1: 3289, 
3058, 3033, 2968, 2901, 1710, 1612, 1472, 1356, 1293, 
1260, 1233, 1193, 1154, 1127, 1093, 1072, 1052, 1024, 
1005, 991, 948, 915, 857, 784, 753, 703, 687, 653, 623, 
588, 532. 1H NMR spectrum, δ, ppm: 2.67 (3H, s, CH3); 
3.22–3.30 (1H, m, 2-CH2); 3.40–3.46 and 3.86–3.93 (2H, 
m, 3-CH2); 4.51–4.56 (2H, m, 2-CH2); 6.94–7.01 (3Н, m, 
H-7', H Ph); 7.14–7.18 (1H, m, H-5'); 7.20–7.32 (3H, m, 
H Ph); 7.43–7.48 (1H, m, H-6'); 7.53–7.56 (1H, m, H-4'); 
9.98 (1H, s, NH). 13C NMR spectrum, δ, ppm: 25.8 (CH3); 
47.9 (C-3); 62.8 (C-2); 71.7 (C-7); 102.9 (C-7a); 108.6 
(C-7'); 121.6 (C-3a'); 122.4 (C-5'); 126.0 (C-2,6); 127.7 
(C-3,5); 127.9 (C-4'); 129.0 (C-4 Ph); 130.8 (C-6'); 134.2 
(C-1 Ph); 144.2 (C-7'); 172.0 (C-2'); 191.9 (C-5). 15N NMR 
spectrum, δ, ppm (J, Hz): 244.7 (N-4); –246.9 (d, 1J = 96.6, 
6-NH); –252.0 (N-1'). Mass spectrum, m/z (Irel, %): 352 
[M+H]+ (100). Mass spectrum, m/z (Irel, %): 350 [M–H]
– (100). 
Found, %: C 65.12; H 5.01; N 11.72; S 9.28. C19H17N3O2S. 
Calculated, %: C 64.94; H 4.88; N 11.96; S 9.12. 
Conversion of compounds 6a,e,f to compounds 5a,f 
and 9e. P2O5 (43 mg, 0.30 mmol) was added portionwise 
to a stirred solution of compound 6a,e,f (0.20 mmol) in 
CHCl3 (4.0 ml) at room temperature. After 45 min, the 
yellow solution was filtered through a short column of 
silica gel. The filtrate was evaporated to dryness, and the 
residue was crystallized. From compounds 6a,f, com-
pounds 5a,f, identical in all respect to those prepared from 
compounds 2a,f, were obtained in 59 and 73% yields, 
respectively. From compound 6e, colorless compound 9e 
was obtained in 39% yield besides compound 7e (5%). 
2-(Benzylsulfanyl)-3-(2-hydroxyethyl)-5-phenyl-3,5-
dihydro-4H-imidazo[4,5-c]quinolin-4-one (9e). Colorless 
solid. Mp 182–186°C (hexane–benzene). IR spectrum, ν, cm–1: 
3317, 3061, 3031, 2962, 1670, 1575, 1492, 1456, 1430, 
1359, 1309, 1247, 1223, 1163, 1128, 1056, 1036, 947, 852, 
757, 702, 681, 666, 607, 563, 546. 1H NMR spectrum, 
δ, ppm (J, Hz): 3.64–3.69 (2H, m, CH2O); 4.32–4.36 (2H, 
m, NCH2); 4.64 (2H, s, SCH2); 4.96 (1H, t, J = 6.9, OH); 
6.55–6.59 (1Н, m, H-6); 7.24–7.37 (7H, m, H-7,8, 
H-2,3,4,5,6 5-Ph); 7.47–7.51 (2H, m, H-2,6 CH2Ph); 7.58–
7.62 (1H, m, H-4 CH2Ph); 7.62–7.66 (2H, m, H-3,5 
CH2Ph); 8.23–8.27 (1H, m, H-9). 
13C NMR spectrum, 
δ, ppm: 36.5 (SCH2); 48.0 (NCH2); 60.1 (CH2O); 116.0 (C-9a); 
116.3 (C-6); 121.1 (C-3a); 121.8 (C-9); 122.6 (C-8); 127.5 
(C-4 5-Ph); 128.2 (C-7); 128.5 (C-2,6 5-Ph); 128.8 (C-4 
CH2Ph); 129.0 (C-2,6 CH2Ph); 129.6 (C-3,5 5-Ph); 130.0 
(C-3,5 CH2Ph); 137.4 (C-1 CH2Ph); 137.6 (C-1 5-Ph); 
138.4 (C-5a); 143.9 (C-9b); 152.5 (C-2); 154.1 (C-4). 
15N NMR spectrum, δ, ppm: –137.2 (N-1); –217.6 (N-3);  
–220.9 (N-5). Mass spectrum, m/z (Irel, %): 877 [2M+Na]
+ 
(5), 466 [M+K]+ (8), 450 [M+Na]+ (63), 428 [M+H]+ 
(100). Mass spectrum, m/z (Irel, %): 426 [M–H]
– (100). 
Found, %: C 70.46; H 5.09; N 9.56; S 7.47. C25H21N3O2S. 
Calculated, %: C 70.24; H 4.95; N 9.83; S 7.50. 
 
Supplementary information file containing 1H, 13C, and 
1H–15N HMBC NMR spectra of the synthesized compounds 
is available at the journal website http://hgs.osi.lv. 
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